divislab glp-1 novo nordisk Nordisk's business trails Eli Lilly Novo Nordisk Drops Hims &
Description
Receive a personalized plan
The China Center for Drug Evaluation (CDE) announced that Shiling Pharma's semaglutide nasal spray has been approved for clinical trials for long-term weight management in adults (obese and overweight)
This article thoroughly traces the developmental milestones of GLP-1 drugs, from their initial discovery to their clinical application, detailing the evolution of diverse GLP-1 medications along with their distinct pharmacological properties
### Competing Interest Statement TR, IG, TK, YW, DT are employees of Olio Labs Incorporated
